Cantabio Pharmaceuticals, Inc. (CTBO) Stock Analysis
DELISTED
What happened to Cantabio Pharmaceuticals, Inc. (CTBO) stock?
Cantabio Pharmaceuticals, Inc. (CTBO) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Cantabio Pharmaceuticals, Inc. (CTBO). Cantabio Pharmaceuticals, Inc. is a preclinical biotechnology company developing novel therapies for neurodegenerative diseases like Parkinson's and Alzheimer's. Its pipeline includes small molecule and engineered protein programs targeting DJ-1, Tau, and Aß proteins.
Last analyzed: Jun 15, 2026Cantabio Pharmaceuticals, Inc. (CTBO) Healthcare & Pipeline Overview
CTBO OTC Market Information
CTBO trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy CTBO shares?
No. CTBO stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CTBO elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CTBO stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Cantabio Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.